Rabies is a zoonotic disease (a disease transmitted from animals to humans) caused by the rabies virus. Rabies is a virus that is usually transmitted by animal bites or scratches.Animal anti rabies vaccine is an effective prophylactic injection

Market Analysis and Insights: Global Animal Anti Rabies Vaccine Market
The global Animal Anti Rabies Vaccine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Animal Anti Rabies Vaccine Scope and Market Size
The global Animal Anti Rabies Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Anti Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Vero Cell Rabies Vaccine
Baby Hamster Kidney (BHK) Rabies Vaccine
Chick Embryo Cell Rabies Vaccine
Other

Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis

The Animal Anti Rabies Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Animal Anti Rabies Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sanofi
GSK
Merck
Yisheng Group
Serum Institute of India
Cadila Pharmaceuticals
Boehringer Ingelheim
Liaoning Chengda